Literature DB >> 9632812

Involvement of prolonged ras activation in thrombopoietin-induced megakaryocytic differentiation of a human factor-dependent hematopoietic cell line.

I Matsumura1, K Nakajima, H Wakao, S Hattori, K Hashimoto, H Sugahara, T Kato, H Miyazaki, T Hirano, Y Kanakura.   

Abstract

Thrombopoietin (TPO) is a hematopoietic growth factor that plays fundamental roles is both megakaryopoiesis and thrombopoiesis through binding to its receptor, c-mpl. Although TPO has been shown to activate various types of intracellular signaling molecules, such as the Janus family of protein tyrosine kinases, signal transducers and activators of transcription (STATs), and ras, the precise mechanisms underlying TPO-induced proliferation and differentiation remain unknown. In an effort to clarify the mechanisms of TPO-induced proliferation and differentiation, c-mpl was introduced into F-36P, a human interleukin-3 (IL-3)-dependent erythroleukemia cell line, and the effects of TPO on the c-mpl-transfected F-36P (F-36P-mpl) cells were investigated. F-36P-mpl cells were found to proliferate and differentiate at a high rate into mature megakaryocytes in response to TPO. Dominant-negative (dn) forms of STAT1, STAT3, STAT5, and ras were inducibly expressed in F-36P-mpl cells, and their effects on TPO-induced proliferation and megakaryocytic differentiation were analyzed. Among these dn molecules, both dn ras and dn STAT5 reduced TPO- or IL-3-induced proliferation of F-36P-mpl cells by approximately 30%, and only dn ras could inhibit TPO-induced megakaryocytic differentiation. In accord with this result, overexpression of activated ras (H-rasG12V) for 5 days led to megakaryocytic differentiation of F-36P-mpl cells. In a time course analysis on H-rasG12V-induced differentiation, activation of the ras pathway for 24 to 28 h was required and sufficient to induce megakaryocytic differentiation. Consistent with this result, the treatment of F-36P-mpl cells with TPO was able to induce prolonged activation of ras for more than 24 h, whereas IL-3 had only a transient effect. These results suggest that prolonged ras activation may be involved in TPO-induced megakaryocytic differentiation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9632812      PMCID: PMC109012          DOI: 10.1128/MCB.18.7.4282

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

1.  Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway.

Authors:  M C Rouyez; C Boucheron; S Gisselbrecht; I Dusanter-Fourt; F Porteu
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Activation of the mitogen-activated protein kinase pathway is involved in and sufficient for megakaryocytic differentiation of CMK cells.

Authors:  A S Melemed; J W Ryder; T A Vik
Journal:  Blood       Date:  1997-11-01       Impact factor: 22.113

3.  STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression.

Authors:  G M Feldman; L A Rosenthal; X Liu; M P Hayes; A Wynshaw-Boris; W J Leonard; L Hennighausen; D S Finbloom
Journal:  Blood       Date:  1997-09-01       Impact factor: 22.113

4.  Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis.

Authors:  T Kanai; S Hirohashi; M Noguchi; Y Shimoyama; Y Shimosato; S Noguchi; S Nishimura; O Abe
Journal:  Jpn J Cancer Res       Date:  1987-12

5.  A possible involvement of Stat5 in erythropoietin-induced hemoglobin synthesis.

Authors:  H Wakao; D Chida; J E Damen; G Krystal; A Miyajima
Journal:  Biochem Biophys Res Commun       Date:  1997-05-08       Impact factor: 3.575

6.  Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.

Authors:  J G Drachman; K Kaushansky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

7.  Megakaryocytic differentiation induced by constitutive activation of mitogen-activated protein kinase kinase.

Authors:  A M Whalen; S C Galasinski; P S Shapiro; T S Nahreini; N G Ahn
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

8.  Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.

Authors:  I Matsumura; J Ishikawa; K Nakajima; K Oritani; Y Tomiyama; J Miyagawa; T Kato; H Miyazaki; Y Matsuzawa; Y Kanakura
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

9.  Interaction of AP-2, a monoclonal antibody specific for the human platelet glycoprotein IIb-IIIa complex, with intact platelets.

Authors:  D Pidard; R R Montgomery; J S Bennett; T J Kunicki
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Establishment and erythroid differentiation of a cytokine-dependent human leukemic cell line F-36: a parental line requiring granulocyte-macrophage colony-stimulating factor or interleukin-3, and a subline requiring erythropoietin.

Authors:  S Chiba; F Takaku; T Tange; K Shibuya; C Misawa; K Sasaki; K Miyagawa; Y Yazaki; H Hirai
Journal:  Blood       Date:  1991-11-01       Impact factor: 22.113

View more
  15 in total

1.  Role of Erk1/2 signaling in the regulation of neutrophil versus monocyte development in response to G-CSF and M-CSF.

Authors:  Nan Hu; Yaling Qiu; Fan Dong
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Phosphorylated c-Mpl tyrosine 591 regulates thrombopoietin-induced signaling.

Authors:  Veena Sangkhae; Sebastian Jonas Saur; Alexis Kaushansky; Kenneth Kaushansky; Ian Stuart Hitchcock
Journal:  Exp Hematol       Date:  2014-03-04       Impact factor: 3.084

3.  Induced expression and association of the Mona/Gads adapter and Gab3 scaffolding protein during monocyte/macrophage differentiation.

Authors:  Caroline Bourgin; Roland P Bourette; Sylvie Arnaud; Yan Liu; Larry R Rohrschneider; Guy Mouchiroud
Journal:  Mol Cell Biol       Date:  2002-06       Impact factor: 4.272

4.  An ENU-induced recessive mutation in Mpl leads to thrombocytopenia with overdominance.

Authors:  E Ricky Chan; Heather Lavender; Geqiang Li; Peter Haviernik; Kevin D Bunting; Mark D Adams
Journal:  Exp Hematol       Date:  2008-12-06       Impact factor: 3.084

5.  A senescence-like cell-cycle arrest occurs during megakaryocytic maturation: implications for physiological and pathological megakaryocytic proliferation.

Authors:  Rodolphe Besancenot; Ronan Chaligné; Carole Tonetti; Florence Pasquier; Caroline Marty; Yann Lécluse; William Vainchenker; Stefan N Constantinescu; Stéphane Giraudier
Journal:  PLoS Biol       Date:  2010-09-07       Impact factor: 8.029

Review 6.  Molecular control of megakaryopoiesis and thrombopoiesis.

Authors:  Itaru Matsumura; Yuzuru Kanakura
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

7.  Structure of the receptor-binding domain of human thrombopoietin determined by complexation with a neutralizing antibody fragment.

Authors:  Michael D Feese; Taro Tamada; Yoichi Kato; Yoshitake Maeda; Masako Hirose; Yasuko Matsukura; Hideki Shigematsu; Takanori Muto; Atsushi Matsumoto; Hiroshi Watarai; Kinya Ogami; Tomoyuki Tahara; Takashi Kato; Hiroshi Miyazaki; Ryota Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

8.  Extracellular signal-regulated kinase induces the megakaryocyte GPIIb/CD41 gene through MafB/Kreisler.

Authors:  Joel R Sevinsky; Anne M Whalen; Natalie G Ahn
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

9.  Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.

Authors:  Sebastian Dütting; Timo Vögtle; Martina Morowski; Sarah Schiessl; Carmen M Schäfer; Stephanie K Watson; Craig E Hughes; Jochen A Ackermann; Daniel Radtke; Heike M Hermanns; Steve P Watson; Lars Nitschke; Bernhard Nieswandt
Journal:  Circ Res       Date:  2013-11-21       Impact factor: 17.367

10.  STAT5 and Oct-1 form a stable complex that modulates cyclin D1 expression.

Authors:  Sophie Magné; Sandrine Caron; Martine Charon; Marie-Christine Rouyez; Isabelle Dusanter-Fourt
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.